1[1]Piper JM, Matanoski GM, Tonascia T. Bladder cancer in young woman[J]. Am J Epidemiology, 1986,6:1033-1042.
2[2]Blot WJ,Fraumeni JF. Geographic Patterns of boadder cancer in the united states[J]. JNCI, 1978,61:1017.
3[3]Axtell IM,Asire AG,Myers MH. Cancer patient Survival:A report from cancer surveillance, Epidemiology, and end resuts (SEER) program[C]. Washington DC: USGPO, 1976.
4[4]Mallemgard A,Carstensen B,Norg ard N,et al. Trend in the incidence of the kidney pelvis,ureter and bladder in danmark 1943-1988[J ]. Scand J Ruol Nephrol, 1993,27: 327.
5[5]Nakata S, Yamanaka H. Epidemiology of urological cancer death in Japan[J]. Int J Urol, 1994,1:114.
6[6]Rehn L. Blasengesch beiulste fuchsin-arbeitern[J]. Arch Klin Chit,1985,50:588.
7[7]Chiang HS,Guo HR, Hong GL,et al. The incidence of bladder cancer in the black foot disease Area in Taiwan[J]. British Journal of Urology,1993,71:274.
8[8]Johansson SL,Cohen SM. Epidemiolgy and etiology of boadder can cer[J]. Semin Surg Oncol, 1997,15: 291.
9[9]Trichern AR,Mostafa MH,Spiege Chalder B,et al. Urinary mitrate,nitrite and N-nitroso compoud in bladder cancer patients with schistosomiasis[J]. IARC Sci Publ, 1991,105:17.
10[10]Rosin MP,Saadel DZ,Ward AJ,et al. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients [J ]. Mutat Res, 1994, 305:283.
